Skip to Search
Skip to Navigation
Skip to Main Content
Skip to Footer
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
User Login
Username
*
Password
*
Administration Login
×
Google Translate
Select language
English
French
German
Italian
Portuguese
Spanish
RESEARCH
Powered by EBSCO
Menu
Site Search
Search Options
Curated Discovery
More Research
Publication Finder
Google Scholar
All
COVID-19 Related Subjects Only
Back to COVID-19 Information Portal
Open Access Resources
Most Viewed Articles from NEJM
Item request has been placed!
×
Item request cannot be made.
×
Processing Request
BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting
SARS-CoV-2 Antibody Response in Persons with Past Natural Infection
Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination
Antibody Responses in Seropositive Persons after a Single Dose of SARS-CoV-2 mRNA Vaccine
Neutralization of SARS-CoV-2 Variants B.1.429 and B.1.351
Neutralizing Response against Variants after SARS-CoV-2 Infection and One Dose of BNT162b2
Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19
Susceptibility of Circulating SARS-CoV-2 Variants to Neutralization
Glucose-Lowering Drugs to Reduce Cardiovascular Risk in Type 2 Diabetes
Delayed Large Local Reactions to mRNA-1273 Vaccine against SARS-CoV-2
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »
×
